Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Sentinel Diagnostics

Sentinel Diagnostics develops and manufactures in-vitro diagnostic medical devices for routine analysis and specific ... read more Featured Products: More products

Download Mobile App





Sentinel Diagnostics Demonstrates New SENTiNAT 200 and STAT-NAT Kits for Infectious Diseases

By LabMedica International staff writers
Posted on 14 Nov 2023

Sentinel Diagnostics (Milano, Italy) is demonstrating the new SENTiNAT 200 and its panel of STAT-NAT kits for infectious diseases at MEDICA 2023. More...

SENTiNAT 200 is a fully automated sample-to-result system for DNA/RNA extraction, PCR setup, and amplification that includes two integrated thermal cyclers and the analysis software FastFinder. The system combines throughput, automation, and flexibility to better adapt to the various laboratory needs. It can perform multiparametric analysis of up to 15 viruses in the same run, processing from one up to 48 samples in four hours. The intuitive software that guides the operator through all the phases of the instrument setup and the barcode reader for samples and reagents help to reduce human errors. The operator can access to the data available on the Cloud anytime anywhere, to optimize the reporting time keeping full control over the results.

SENTiNAT 200 is designed to work with STAT-NAT SN200 kits which are also being highlighted at MEDICA 2023. STAT-NAT (Stabilized Amplification Technology) kits are based on Sentinel’s proprietary technology that has been developed with a new protective compound able to stabilize the activity of enzymes for a very long time with no temperature-controlled storage requirements. In addition to the STAT-NAT SN200 product line designed to be used with SENTIENT 200, Sentinel is showcasing the STAT-NAT kits designed for manual use and useful for low throughput requirements and STAT-NAT Flex kits designed for the semi-automated use and useful for low to medium throughput requirements.

Related Links:
Sentinel Diagnostics 


Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Portable Electronic Pipette
Mini 96
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
New
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The tool enables scientists to track real-time fluctuations in T cell function with unprecedented speed and precision (Photo courtesy of Shutterstock)

Luminescent Probe Measures Immune Cell Activity in Real Time

The human immune system plays a vital role in defending against disease, but its activity must be precisely monitored to ensure effective treatment in cancer therapy, autoimmune disorders, and organ transplants.... Read more

Industry

view channel
Image: The collaboration supports clinical validation and regulatory submissions of the new T1D 4-plex assay on Revvity’s GSP instrument (Photo courtesy of Revvity)

Revvity and Sanofi Collaborate on Program to Revolutionize Early Detection of Type 1 Diabetes

Type 1 diabetes (T1D) is a lifelong autoimmune condition in which the immune system destroys the pancreas’s insulin-producing beta cells, leading to dependence on insulin therapy. Early detection is critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.